We and others have reported that mesothelin (MSLN) is widely expressed in human cancers; for example, the majority (80–90%) of PC and ovarian cancers and 100% of epithelial mesotheliomas highly express MSLN [32,33,34,35,36,37,38,39]. This evidence concerns the gene MSLN and pachyonychia congenita.